168 related articles for article (PubMed ID: 31432172)
1. Ulinastatin ameliorates LPS‑induced pulmonary inflammation and injury by blocking the MAPK/NF‑κB signaling pathways in rats.
Ju M; He H; Chen S; Liu Y; Liu Y; Pan S; Zheng Y; Xuan L; Zhu D; Luo Z
Mol Med Rep; 2019 Oct; 20(4):3347-3354. PubMed ID: 31432172
[TBL] [Abstract][Full Text] [Related]
2. Penehyclidine hydrochloride alleviates lipopolysaccharide‑induced acute lung injury in rats: Potential role of caveolin‑1 expression upregulation.
Wu X; Kong Q; Xia Z; Zhan L; Duan W; Song X
Int J Mol Med; 2019 May; 43(5):2064-2074. PubMed ID: 30864740
[TBL] [Abstract][Full Text] [Related]
3. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
4. Structured triglyceride attenuates lung injury and inflammation in lipopolysaccharide‑induced acute lung injury by enhancing GPR120 expression.
Sun H; Pang Y; Zhao D; Li W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880584
[TBL] [Abstract][Full Text] [Related]
5. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
6. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
[TBL] [Abstract][Full Text] [Related]
8. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 antagonist attenuates lung inflammation through inhibition of the ERK1/2 and NF-κB pathway in LPS-induced acute lung injury.
Li TJ; Zhao LL; Qiu J; Zhang HY; Bai GX; Chen L
Mol Med Rep; 2017 Aug; 16(2):2225-2232. PubMed ID: 28656298
[TBL] [Abstract][Full Text] [Related]
10. Apelin‑36 protects against lipopolysaccharide‑induced acute lung injury by inhibiting the ASK1/MAPK signaling pathway.
He Q; Wang Y; Yang H; Wang J; Zhang J; Liu D
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179090
[TBL] [Abstract][Full Text] [Related]
11. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
12. miR‑26a‑5p alleviates lipopolysaccharide‑induced acute lung injury by targeting the connective tissue growth factor.
Li H; Yang T; Fei Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179083
[TBL] [Abstract][Full Text] [Related]
13. Expression level of 12-amino acid triggering receptor on myeloid cells-like transcript 1 derived peptide alleviates lipopolysaccharide-induced acute lung injury in mice.
Shi R; Zhang J; Peng Z; Yuan S; Gao S; Chen L; Yuan Y
Int J Mol Med; 2018 Apr; 41(4):2159-2168. PubMed ID: 29393375
[TBL] [Abstract][Full Text] [Related]
14. [Glabridin reduces lipopolysaccharide-induced lung injury in rats by inhibiting p38 mitogen activated protein kinase/extracellular regulated protein kinases signaling pathway].
Zhang LP; Li JG
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(48):3893-3897. PubMed ID: 28057160
[No Abstract] [Full Text] [Related]
15. Anti‑inflammatory effect of salusin‑β knockdown on LPS‑activated alveolar macrophages via NF‑κB inhibition and HO‑1 activation.
Chen S; Hu Y; Zhang J; Zhang P
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300078
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats.
Li N; Song Y; Zhao W; Han T; Lin S; Ramirez O; Liang L
BMC Physiol; 2016 Dec; 16(1):7. PubMed ID: 28031043
[TBL] [Abstract][Full Text] [Related]
17. [Protective effect of synthetic salidroside on acute lung injury in rats].
Huang Q; Cai YC; Wei XL; Wu JL; Mei RH; Hu XL
Sheng Li Xue Bao; 2017 Jun; 69(3):291-297. PubMed ID: 28638921
[TBL] [Abstract][Full Text] [Related]
18. Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
Liu F; Sun GQ; Gao HY; Li RS; Soromou LW; Chen N; Deng YH; Feng HH
J Surg Res; 2013 Nov; 185(1):300-9. PubMed ID: 23816246
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of lidocaine on lipopolysaccharide-induced acute lung injury in rats through NF-κB and p38 MAPK signaling pathway and excessive inflammatory responses.
Chen LJ; Ding YB; Ma PL; Jiang SH; Li KZ; Li AZ; Li MC; Shi CX; Du J; Zhou HD
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2099-2108. PubMed ID: 29687869
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
